- Stocks
- Healthcare
- NASDAQ: DMTK

Price (delayed)

$35.51

Market cap

$1.03B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.1

Enterprise value

$809.33M

The quick ratio has soared by 183% YoY

The revenue has surged by 58% year-on-year and by 16% since the previous quarter

DermTech's gross profit has surged by 174% QoQ but it has shrunk by 84% YoY

The gross margin has soared by 163% from the previous quarter but it has plunged by 90% YoY

The net income has dropped by 102% year-on-year and by 23% since the previous quarter

What are the main financial stats of DMTK

Market
Valuations
Earnings

Shares outstanding

28.94M

Market cap

$1.03B

Enterprise value

$809.33M

Price to earnings (P/E)

N/A

Price to book (P/B)

3.98

Price to sales (P/S)

140.74

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

118.13

Revenue

$6.85M

EBIT

-$43.36M

EBITDA

-$42.74M

Free cash flow

-$33.67M

Per share
Balance sheet
Liquidity

EPS

-$2.1

Free cash flow per share

-$1.24

Book value per share

$8.93

Revenue per share

$0.25

TBVPS

$9.76

Total assets

$265.03M

Total liabilities

$8.2M

Debt

$308,000

Equity

$256.83M

Working capital

$254.64M

Debt to equity

0

Current ratio

36.88

Quick ratio

36.64

Net debt/EBITDA

5.11

Margins
Efficiency
Dividend

EBITDA margin

-623.8%

Gross margin

1%

Net margin

-632.3%

Operating margin

-608.7%

Return on assets

-38%

Return on equity

-40.3%

Return on invested capital

-149.2%

Return on capital employed

-16.8%

Return on sales

-632.8%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the DermTech stock price performed over time

Intraday

-1.82%

1 week

6.29%

1 month

-22.42%

1 year

245.43%

YTD

9.46%

QTD

-14.58%

How have DermTech's revenue and profit performed over time

Revenue

$6.85M

Gross profit

$71,000

Operating income

-$41.7M

Net income

-$43.32M

Gross margin

1%

Net margin

-632.3%

DermTech's gross profit has surged by 174% QoQ but it has shrunk by 84% YoY

The gross margin has soared by 163% from the previous quarter but it has plunged by 90% YoY

The net income has dropped by 102% year-on-year and by 23% since the previous quarter

The operating income has plunged by 93% YoY and by 18% from the previous quarter

What is DermTech's growth rate over time

What is DermTech stock price valuation

P/E

N/A

P/B

3.98

P/S

140.74

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

118.13

DermTech's EPS has increased by 7% YoY

The price to book (P/B) is 33% lower than the last 4 quarters average of 5.9

The revenue has surged by 58% year-on-year and by 16% since the previous quarter

The stock's P/S is 47% above its last 4 quarters average of 96.0

How efficient is DermTech business performance

DermTech's return on invested capital has surged by 94% YoY and by 20% QoQ

The return on equity has surged by 52% year-on-year and by 31% since the previous quarter

The company's return on assets rose by 44% YoY and by 29% QoQ

DermTech's ROS has decreased by 32% YoY and by 6% from the previous quarter

What is DMTK's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for DMTK.

How did DermTech financials performed over time

DermTech's current ratio has surged by 199% QoQ and by 181% YoY

The quick ratio has soared by 183% YoY

DermTech's debt is 100% less than its equity

The company's debt to equity has shrunk by 100% QoQ

DermTech's debt has decreased by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.